GFC-101

N/A

Report date: 2024/10/16 16:14:46

Base Information

Drug NameGFC-101
Drug Alias NameGFC101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEarly activation antigen CD69 inhibitors
TargetsEarly activation antigen CD69
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthmaColitis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeneFrontier Corp
China Registration ClassN/A

Develop Information

Active CompaniesGeneFrontier Corp
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthmaColitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A